Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Grindey

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|June 1, 1990
Current status of cancer drug development: failure or limited success?G B Grindey
Cancer|July 1, 1977
Multiple basis of combination chemotherapyE Mihich, G B Grindey
Nucleic Acids Symposium Series|January 1, 1987
Pharmacokinetics of the 5'-triphosphates of arabinosylcytosine and 2',2'-difluorodeoxycytidine in L1210 cellsW Plunkett, G B Grindey
Oncology Research|January 1, 1992
Effect of 2',2'-difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitroS Rockwell, G B Grindey
Cancer Communications|April 1, 1991
Diarylsulfonylureas and radiotherapy. I. In vitro studies with N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)-urea (Sulofenur)S Rockwell, G B Grindey
Cancer Research|July 1, 1975
Effects of allopurinol on the therapeutic efficacy of methotrexateG B Grindey, R G Moran
Journal of Medicinal Chemistry|August 7, 1992
Sulfonylureas: a new class of cancer chemotherapeutic agentsF Mohamadi, M M Spees, G B Grindey
Cancer Research|November 1, 1979
Isolation of a DNA polymerase alpha-associated regulatory protein from calf thymusJ A Steinberg, M Otten, G B Grindey
Cancer Research|September 1, 1979
Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidineJ J Kinahan, M Otten, G B Grindey
Antibiotics and Chemotherapy|January 1, 1978
Modulation versus rescue of antimetabolite toxicity by salvage metabolites administered by continuous infusionG B Grindey, J H Semon, Z P Pavelic
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|June 1, 1990
Current status of cancer drug development: failure or limited success?G B Grindey
Cancer|July 1, 1977
Multiple basis of combination chemotherapyE Mihich, G B Grindey
Nucleic Acids Symposium Series|January 1, 1987
Pharmacokinetics of the 5'-triphosphates of arabinosylcytosine and 2',2'-difluorodeoxycytidine in L1210 cellsW Plunkett, G B Grindey
Oncology Research|January 1, 1992
Effect of 2',2'-difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitroS Rockwell, G B Grindey
Cancer Communications|April 1, 1991
Diarylsulfonylureas and radiotherapy. I. In vitro studies with N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)-urea (Sulofenur)S Rockwell, G B Grindey
Cancer Research|July 1, 1975
Effects of allopurinol on the therapeutic efficacy of methotrexateG B Grindey, R G Moran
Journal of Medicinal Chemistry|August 7, 1992
Sulfonylureas: a new class of cancer chemotherapeutic agentsF Mohamadi, M M Spees, G B Grindey
Cancer Research|November 1, 1979
Isolation of a DNA polymerase alpha-associated regulatory protein from calf thymusJ A Steinberg, M Otten, G B Grindey
Cancer Research|September 1, 1979
Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidineJ J Kinahan, M Otten, G B Grindey
Antibiotics and Chemotherapy|January 1, 1978
Modulation versus rescue of antimetabolite toxicity by salvage metabolites administered by continuous infusionG B Grindey, J H Semon, Z P Pavelic
Pageof 6